FDA granted Fast Track to Lu AH69593 for narcolepsy type 1.
FDA · Jul 26🇺🇸 United States & Americas
Americas Pharma Intelligence Center
0 fda approvals · 0 trial updates · 0 m&a / licensing · 19 regulatory actions
4.2K drugs · 800 companies · 335 pipeline programs · 1.6K patents Latest signals Global markets overview Data sources Editorial policy Authors
YMYL editorial standards Written and reviewed by the NovaPharmaNews editorial team Editorial policy Methodology Full team
Featured Intelligence
AACR/ASCO Methods in Clinical 2026 Preview
Why it matters Dates and site are fixed: July 26–31, 2026 at The Hythe, Vail, Colorado.
Watch next Follow source filings, related entities, and follow-on disclosures.
AI Snapshot
What happened today in Americas pharma?
AACR/ASCO Methods in Clinical 2026 Preview is the lead FDA market signal. Dates and site are fixed: July 26–31, 2026 at The Hythe, Vail, Colorado.
- Dates and site are fixed: July 26–31, 2026 at The Hythe, Vail, Colorado.
- The FDA approved Merck's LIPFENDRA (enlicitide) 20 mg on July 16, 2026 as the first oral PCSK9 inhibitor for LDL-C lowering.
FDA Market Pulse
Data snapshot · 2026-06-17 21 FDA catalysts (7d) Regulatory & clinical
40 Stories this week Published intelligence
289 Breaking alerts Active now
50 Upcoming events In this market
High-Authority Trackers
Daily-use intelligence tools
0 FDA Tracker Drug approvals and label decisions 0 Clinical Trial Tracker Phase I-IV updates and safety signals 0 M&A Tracker Deals, licensing, and partnerships IP Patent Expiry Tracker Loss-of-exclusivity opportunities 5 Upcoming Catalysts PDUFA dates, readouts, conferences PDF Research Library Whitepapers and market reports
Market Signals
What is moving in Americas pharma
Regulatory
View allMonopar initiated a rolling NDA for ALXN1840 (tiomolybdate choline) in Wilson disease.
FDA · Jul 26OSVYRTI (denosumab-desu) launched as an interchangeable biosimilar to Prolia; JUBEREQ to XGEVA.
FDA · Jul 26Clinical & Trials
View allNo active signals in this lane yet. Explore the full archive.
Corporate & Deals
View allNo active signals in this lane yet. Explore the full archive.
Trending Entity Network
Companies, drugs, and diseases to follow
Trending Companies
Profile links Pfizer news, pipeline programs, patents, approvals, and FDA market signals.
Profile links Janssen Research & news, pipeline programs, patents, approvals, and FDA market signals.
Profile links HOFFMANN-LA ROCHE news, pipeline programs, patents, approvals, and FDA market signals.
Profile links Novartis news, pipeline programs, patents, approvals, and FDA market signals.
Profile links MSD Merck Sharp news, pipeline programs, patents, approvals, and FDA market signals.
Trending Drugs
pembrolizumab connects approvals, trials, patents, competitors, and company exposure.
semaglutide connects approvals, trials, patents, competitors, and company exposure.
tirzepatide connects approvals, trials, patents, competitors, and company exposure.
nivolumab connects approvals, trials, patents, competitors, and company exposure.
dupilumab connects approvals, trials, patents, competitors, and company exposure.
Trending Diseases & Hubs
Oncology HubFDA oncology news, drugs, trials, events, and companies.
Obesity HubGLP-1, GIP/GLP-1, metabolic approvals, trials, and market access.
Rare Disease HubOrphan drugs, genetic medicines, designations, and sponsor activity.
Neurology HubAlzheimer’s, CNS, neuromuscular, and neurodegeneration intelligence.
Cell & Gene TherapyAdvanced therapies, manufacturing, approval pathways, and readouts.
Pharma Knowledge Graph
Disease to drug to trial to company to approval
Every signal routes into structured entity pages so readers can move from a regional market event to related drugs, sponsors, patents, trials, regulators, events, and market impact.
DiseaseDrugTrialCompanyRegulatorApprovalMarket Impact
Event Ecosystem
This week, must-attend events, and coverage paths
AACR/ASCO Methods in Clinical Cancer Research Workshop 2026
Major congress with 0 indexed presentations and 0 companies tracked. · Vail, Colorado
Annual NPPA Conference 2026
Major congress with 0 indexed presentations and 0 companies tracked. · Las Vegas, USA
Future Biotech Expo 2026
Major congress with 0 indexed presentations and 0 companies tracked. · Houston, United States
Ai4 2026 (Healthcare Tracks)
Major congress with 0 indexed presentations and 0 companies tracked. · Las Vegas, USA
2026 Technology Showcase
Major congress with 0 indexed presentations and 0 companies tracked. · Frederick, USA
Research Library
Whitepapers, reports, and guides
Optimizing Pharmaceutical Manufacturing: The Critical Role of Dew Point Monitoring
This whitepaper highlights the critical importance of dew point monitoring in industrial applications, particularly for ensuring product quality and equipment integrity in pharmaceutical manufacturing.
Pharma R&D ROI: A Multidimensional Framework for AI Investment Success
This whitepaper introduces a multidimensional ROI framework specifically designed for pharmaceutical R&D, enabling companies to better measure and demonstrate the value of AI investments.
Navigating Human Research: Mass General Brigham's IRB Guidance for Ethical Clinical Trials
This whitepaper summarizes Mass General Brigham's Institutional Review Board (IRB) Guidance, offering essential information for researchers and institutions involved in human subject research.
National Drug Control Strategy (2026): A Comprehensive Approach to Combat Drug Addiction
The National Drug Control Strategy (2026) presents a whole-of-government approach to address the drug crisis, emphasizing prevention, treatment, and community resilience.
Regional Intelligence FAQ
About the Americas Pharma Intelligence Center
What is the Americas Pharma Intelligence Center?
It is NovaPharmaNews' regional hub for FDA approvals, clinical trial updates, company news, events, patents, and market-moving pharmaceutical intelligence.
Which regulator does this regional page track?
The primary regulator tracked on this page is Food and Drug Administration, with related drug, company, clinical trial, patent, and event intelligence.
Who reviews FDA coverage?
FDA coverage is written and reviewed by the NovaPharmaNews editorial team. See our editorial policy and author directory.
Partner directory
Browse all suppliers → Pharma Suppliers & Vendors
Independent supplier listings for manufacturing, CRO, and regulatory services.
Partner listings are separate from our editorial newsroom. Supplier profiles do not influence news coverage, rankings, or editorial decisions.
BiotiumBiotium is a private life science reagent manufacturer based in Fremont, California, speci…
AI-Enabled Lab Automation SolutionsCenevo is an AI-enabled lab automation and data management software company built around M…
AdipoGen Life SciencesAdipoGen Life Sciences is a private life science reagents manufacturer and global distribu…